Public health
FIOCRUZ – 120 YEARS

Beyond Manguinhos
FIOCRUZ graduates made significant achievements in public and private institutions in Brazil and abroad
By Suzel Tunes
FIOCRUZ – 120 YEARS

A continuum of challenges
From the bubonic plague to Zika fever, the Oswaldo Cruz Foundation’s 120-year history has been punctuated by a succession of novel diseases and related discoveries
By Suzel Tunes
FIOCRUZ – 120 YEARS

No rest on the anniversary
FIOCRUZ celebrates 120 years of public health literature, research, assistance, and teaching
By Suzel Tunes
Research during the quarantine

“When I woke up, it was wonderful to realize that I was still alive.”
I was infected by the novel coronavirus in late February, while attending two scientific conferences—one in Lisbon and another in Jerusalem. Both had many participants and took place at the beginning of the COVID-19 pandemic. I returned to São Paulo on March 5th. On the 8th, I attended the release of my biography, called Não,... View Article
COVID-19

Restaurants spread infections in the United States
A study suggests that the majority of novel coronavirus infections recorded between March and May this year occured in restaurants in metropolitan areas in the USA
By Redação
Public policy

A paradox on the table
Food insecurity challenges faced by Brazil, one of the largest agricultural producers in the world
COVID-19

The mystery of reinfections
Evidence that SARS-CoV-2 can infect the same person more than once is challenging our understanding of the virus and how we combat the disease
By Tiago Jokura
COVID-19

Study determines Chinese vaccine is safe
CoronaVac is safe and has no serious side effects
By Redação
COVID-19

Manaus and herd immunity
Weeks after the number of new COVID-19 cases and deaths peaked in Manaus, the city appeared to have achieved herd immunity
By Redação
COVID-19

Effect on births
Fearful of contracting the novel coronavirus, many pregnant women are putting off going to the hospital until they are at a more advanced stage of labor
By Redação
COVID-19

Antibody treatment reduces time spent in hospital
American pharmaceutical company Eli Lilly presented the initial results of a clinical trial that used monoclonal antibodies in patients infected with the novel coronavirus
By Redação
COVID-19

Obesity can exacerbate COVID-19
A large-scale study found that obese people infected with SARS-CoV-2 are twice as likely to need medical care
By Redação
Video

Why the Covid-19 vaccine is important
Never before so many vaccines have been developed at the same time against a single disease, nor so rapidly | 7'32
By Redação
COVID-19

The content of fake news
Scientific institutions have created websites to combat fake news
By Redação